Regulatory

RSS

5-HT1A agonist for cognition disorders disclosed

June 21, 1996

AmBisome line extension receives Danish approval

June 21, 1996

FDA approves abbreviated treatment regimen for Vantin

June 21, 1996

Positive phase III results for new Solarase formulation

June 21, 1996

Vivus and Astra sign Muse licensing agreement

June 14, 1996

Schering-Plough seeks Nasonex approval

June 14, 1996

Activase cleared by FDA for ischemic stroke

June 14, 1996

Colchicine/hydroxychloroquine therapy of AD

June 14, 1996

Lithium/nimodipine combination as bipolar I manic disorder treatment

June 14, 1996

Xalatan approved for U.S. market

June 14, 1996